Radioiodine Therapy, commonly known as iodine 131 treatment, is an important part of
modern thyroid cancer treatment and is widely used in advanced nuclear medicine in India.
This therapy is especially recommended after thyroid surgery to destroy any remaining
thyroid tissue or microscopic cancer cells that may still be present in the body. As part of
modern theranostics in India, this treatment combines targeted diagnosis and therapy,
helping doctors treat cancer cells with greater precision. Specialists such as Dr. Swagat Dash
use radioiodine therapy to provide a safe and effective treatment approach for patients with
differentiated thyroid cancers like papillary and follicular thyroid cancer.
The treatment works because thyroid cells naturally absorb iodine. During iodine 131
treatment, a patient receives a capsule or liquid containing radioactive iodine. These
radioactive particles travel through the bloodstream and are absorbed mainly by thyroid
cells and thyroid cancer cells. Once absorbed, the radiation destroys those cells from within
while causing minimal damage to surrounding healthy tissues. This targeted action is why
radioiodine therapy is considered one of the most effective options in best cancer treatment
in India for eligible thyroid cancer patients.
Doctors usually recommend iodine 131 treatment for patients who have undergone thyroid
surgery but may still have remaining thyroid tissue, elevated tumor markers, or a risk of
cancer recurrence. In some cases, it is also used when thyroid cancer has spread to lymph
nodes or other areas of the body. With the advancement of nuclear medicine in India and the
growing role of theranostics in India, radioiodine therapy continues to improve outcomes for
many thyroid cancer patients by offering precise, targeted, and effective treatment.
